Search clinical trials for: HER-2 negative
Total 52828 results
-
Jin-Hee AhnAsan Medical CenterUnknownHER-2 Gene Amplification | HER-2 Protein Overexpression
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSolid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionChina
-
Merrimack PharmaceuticalsCompletedHER-2 Gene AmplificationUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Orum Therapeutics USA, Inc.RecruitingHER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionUnited States
-
Merck Sharp & Dohme LLCCompletedCancers Expressing HER-2 and/or CEA
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
University of MiamiRecruitingStage IV Breast Cancer | HER2-positive Metastatic Breast CancerUnited States
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | HER2/Neu Positive | HLA-A2 Positive Cells Present | Stage IV Ovarian CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)RecruitingHER2-positive Metastatic Breast Cancer | HER-2 Protein Overexpression | HER-2 Positive Malignant Carcinoma of BreastUnited States
-
Istituto Clinico HumanitasCompleted
-
Fuda Cancer Hospital, GuangzhouWithdrawn
-
Sichuan Baili Pharmaceutical Co., Ltd.Recruiting
-
Changhoon YooCompletedCholangiocarcinoma | Biliary Tract Cancer | HER-2 Gene Amplification | HER-2 Protein OverexpressionKorea, Republic of
-
Instituto Nacional de Cancerologia de MexicoCompletedNon-Small Cell Lung Cancer | EGFR | HER-2Mexico
-
Shanghai Zhongshan HospitalUnknownGastric Cancer | HER-2China
-
Centre Hospitalier Universitaire VaudoisNot yet recruitingStroke | Executive DysfunctionSwitzerland
-
Robert WesolowskiCompletedBreast Cancer | Ovarian Cancer | Malignant Solid Tumour | GIST | Malignant Tumor of ColonUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Ontario Clinical Oncology Group (OCOG)Canadian Breast Cancer Research Alliance; Ontario Cancer Research NetworkCompletedMetastatic Breast Cancer | Recurrent Breast CancerCanada
-
Yale UniversityGenentech, Inc.CompletedBreast CancerUnited States
-
ASLAN PharmaceuticalsCompletedStomach Neoplasms | Gastric Cancer | Gastric Neoplasms | Cancer of Stomach | Cancer of the StomachKorea, Republic of
-
Bellicum PharmaceuticalsSuspendedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Solid Tumor, Adult | HER-2 Gene Amplification | HER-2 Protein OverexpressionUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI)WithdrawnBreast Cancer | Gastric Cancer | Ovarian Cancer | Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific
-
University of PennsylvaniaAbramson Cancer Center of the University of PennsylvaniaNo longer availableMetastatic CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAbramson Cancer Center at Penn MedicineCompletedBreast CancerUnited States
-
Cogent Biosciences, Inc.TerminatedSolid Tumor | HER-2 Protein OverexpressionUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnHER2-positive Breast Cancer | Male Breast Cancer | Stage IV Breast CancerUnited States
-
Xiangya Hospital of Central South UniversityNot yet recruiting
-
Henan Cancer HospitalQilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.Not yet recruitingHER-2 Negative Breast Cancer
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
Sun Yat-sen UniversityRecruiting
-
Craig L Slingluff, JrNational Cancer Institute (NCI)CompletedEvaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer (Breast 37)Breast NeoplasmsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruiting
-
Nanjing Chia-tai Tianqing PharmaceuticalRecruitingHR Positive/HER-2 Negative Breast CancerChina
-
Fudan UniversityUnknownHER-2 Negative Breast CancerChina
-
Puma Biotechnology, Inc.TerminatedMetastatic Cervical Cancer | Hormone Receptor-Positive, HER2-Negative Metastatic Breast CancerSpain, Israel, United States, Serbia, France, Ireland, Italy
-
University Hospital, BrestUnknownBreast Neoplasms | HER-2 Gene AmplificationFrance
-
Ying LinRecruitingHer-2 Negative Breast Cancer | HRR Gene MutationChina
-
Fudan UniversityRecruitingHormone Receptor Positive HER-2 Negative Breast CancerChina
-
University Hospital TuebingenUniversity Hospital Freiburg; University Hospital UlmRecruitingHormone Receptor Positive HER-2 Negative Breast CancerGermany
-
National Cancer Institute, NaplesActive, not recruitingMetastatic Breast CancerItaly
-
Morten Mau-SørensenOdense University Hospital; Aarhus University Hospital; Aalborg University HospitalRecruitingEsophageal Squamous Cell Carcinoma | HER-2 Gene Amplification | HER-2 Protein OverexpressionDenmark